Obesity Innovation Summit Agenda

Download the 2024 Agenda
  • Day One | Thursday, July 18th, 2024
  • Day Two | Friday, July 19th, 2024
  • Co-Located Future of Diabetes Care Summit
Day One | Thursday, July 18th, 2024
8:00 AM

Breakfast and Registration

9:00 AM

Chair’s Opening Remarks and Setting the Scene

Adam Kaufman, Advisor and Ex-SVP Healthcare, Weight Watchers

9:10 AM

Keynote Presentation- Understanding and Addressing the Growing Rates of Obesity

  • Understand the major factors that have contributed to the lack of success in curtailing the rise in global obesity prevalence
  • Explore the causes and determinants of obesity
  • Discuss the current approach to chronic obesity care

Tekisha Everette, Executive Vice President, Trust for America’s Health

9:35 AM

Keynote Panel Discussion with Open Q&A- Building A Comprehensive and Multimodal Approach to Obesity Care

Recent times have seen a rise in anti-obesity medications and surgery to tackle obesity alongside an increase in lifestyle medical approaches. It is now becoming clear that to effectively combat obesity as a chronic disease, obesity treatment will require a multidisciplinary and multi-system approach within obesity medicine.

  • How can various disciplines within lifestyle medicine in conjunction with drug /surgery-based medical interventions be effectively integrated to optimise weight management outcomes?
  • What steps can be taken to help overcome challenges patients face in adhering to lifestyle modifications?
  • What healthcare model and approach can be taken to avoid the reoccurrence of obesity?
  • What can be done to help different segments of the patient population derive greater benefits from combined multimodal treatment plans?
  • How can we promote greater collaboration amongst different industry stakeholders to create a comprehensive and integrated approach to tackling obesity?
  • How can digital health tools provide better access to personalised obesity care plans?

Juliana Simonetti, Director, Obesity Medicine & Co-Director, Comprehensive Weight Management Program, University of Utah Health

John Cleek, Medical Director, Obesity Medicine, Roper St. Francis Healthcare; Ex-President, American Board of Obesity Medicine

Jessica Inwood, Director of Medical Weight Management, Southcoast Health 

Angela Fitch, President, Obesity Medicine Association; CMO, Knownwell

10:20 AM

Morning Refreshments and Networking

11:00 AM

Presentation- Amplifying the Voice of People with Obesity to Support Personalised Care 

  • Understand the challenges and needs faced by people with obesity in healthcare settings,
  • Explore the benefits of patient-centred care models in obesity management,
  • Discuss the tools and resources required to empower patients for long-term weight management success.

Joe Nadglowski, President and CEO, Obesity Action Coalition

11:25 AM

Presentation: Transforming Obesity Treatment with Precision Medicine  

  • Defining the foundations of care for managing medically complex patients 
  • Learn how these foundations can be personalized to meet individual patient needs
  • Deep dive into real-world case scenarios

Eduardo Grunvald, Director, Obesity Medicine, University of California, San Diego Medical Center

11:50 AM

Presentation- Diet as a Vital Sign: Evidence-Based Nutrition in Action

  • Explore how and why diet should be used as a vital sign
  • Understand the principles of precision nutrition and its role in personalized healthcare
  • Deep dive into how the use of evidence-based precision nutrition can be used in combination with other methods to manage the chronicity of obesity
12:15 PM

Panel Discussion with Open Q&A- Enhancing Health Literacy Amongst Medical Professionals: Breaking Stigma and Misinformation 

Recent surveys have shown that up to 58% of providers believe obesity is caused solely by lifestyle choices but this stigmatisation is known to prevent patients from seeking vital medical care for obesity. This stigmatisation and prejudice needs to be broken through in order to enable effective obesity treatment.

  • What are the wider impacts of societal attitudes towards obesity, body image and social media on the delivery of obesity healthcare and treatment?
  • What are the mental and physical effects of internalized weight bias on patient care and outcomes?
  • What practical interventions and actions can be taken to reduce this stigmatization within the medical field and move beyond blame culture?
  • What lessons can be learnt from the improved destigmatization of other chronic diseases, for example mental health and how can these be successfully applied to in the context of obesity healthcare?
  • How can evidence-based findings be used to challenge weight bias and drive improvement of patient treatment and care?

Bharti Abichandani Shetye, Owner, Dr. Abby’s Weight Management Clinic; Provider Champion, VA MOVE!; Board of Trustees, Obesity Medicine Association

Shagun Bindlish, Mission Chair, American Diabetes Association Northern California

Robyn Pashby, Founder & Clinical Health Psychologist, DC Health Psychology;  National Board of Directors, Obesity Action Coalition

1:00 PM


2:15 PM

Panel Discussion- The Tipping Point in Obesity Healthcare: GLP-1 and GIP Receptor Antagonist Drugs

The roll out of GLP-1 and GIP receptor agonist weight loss drugs has taken the obesity healthcare sector by storm. Contributing to significant reduction in body weight, the quantum of weight-loss effect sets these drugs apart from any drug predecessor. However,  with this new wave of drugs, comes new questions.

  • What will be the main primary and second-order effects of these drugs?
  • What role should healthcare providers play in educating patients about the benefits and risks of these medications and helping them make informed decisions?
  • What factors need to be considered in order to forecast how well someone will respond to these drugs?
  • What are the long-term sustainable applications of these agents?
  • How are these medications evolving how obesity is perceived?
  • How can any concerns about the over-reliance on these medications be addressed?

Carolina Solis-Herrera, Associate Professor and Medical Director Endocrinology, Diabetes and Obesity Clinics, UT Health San Antonio

Disha Narang, Director of Obesity Medicine, Northshore University Health System 

Stephanie Ortiz Page, Medical Director, Metabolic & Weight Management Program, Nuvance Health

3:00 PM

Afternoon Refreshments and Networking

3:35 PM


Linda Golden, Doctor of Nursing Practice, Lomaira™

4:00 PM

Presentation- The Future of Bariatric Surgery and Co-Evolution with New Pharmacologics

  • Explore the effectiveness of using bariatric surgery in combination with pharmacologic management 
  • Delve into how anxieties and biases associated with bariatric surgery can be overcome
  • Understand what the next-decade of bariatric surgery will look like

Sajani Shah, Chief, Division of MIS/Bariatric Surgery & Director of the Weight and Wellness Center, Tufts Medical Center

4:25 PM

Presentation- The Next-Decade of Pediatric Obesity Treatment

  • Discuss current treatment options for pediatric obesity 
  • Describe how the pipeline of advanced therapeutics might change the landscape 
  • Examine barriers to combating the pediatric obesity epidemic

Justin Ryder, Vice Chair of Research for the Department of Surgery, Lurie Children’s Hospital; Associate Professor of Surgery and Pediatrics, Northwestern Feinberg School of Medicine

4:50 PM

Fireside Chat with Open Q&A- The Price Tag For Health: Overcoming Financial Obstacles for Obesity Care

The medical cost of obesity is expected to cost $644 per capita annually from 2020 to 2050, 14% of the total for American health expenditure. With the chronicity of obesity, this expenditure is anticipated to continue to grow but financial coverage for obesity treatment remains variable.

  • What barriers do insurers face in covering different methods for obesity treatment?
  • How can it be ensured that the average American can access care for obesity and new advancements in treatment?
  • How can employers be encouraged to opt-in for obesity treatment coverage for their employees?
  • What are the long-term impacts of the reintroduction of the Treat and Reduce Obesity Act?
  • How can the reimbursement model for obesity treatment take into account the chronicity of the disease and the risks of potential weight regain?

Angie Kalousek, Senior Director, Lifestyle Medicine, Blue Shield of California

Adimika Arthur, CEO & Executive Director, HealthTech for Medicaid (HT4M)

5:35 PM

Chair’s Closing Remarks

5:45 PM

Drinks Reception Hosted By Lomaira™ 

Download the 2024 Agenda
Day Two | Friday, July 19th, 2024
8:00 AM

Breakfast and Registration

9:00 AM

Chair’s Opening Remarks

Adam Kaufman, Advisor and Ex-SVP Healthcare, Weight Watchers

9:10 AM

Presentation- Uncovering the Underlying Genetic Factors of Obesity 

  • Discuss the intricate genetic mechanisms underlying this chronic disease
  • Understand the importance of genetic testing and the identification of genetic mutations
  • Explore how these genetic insights can contribute to individualized care

Juliana Simonetti, Director, Obesity Medicine & Co-Director, Comprehensive Weight Management Program, University of Utah Health

9:35 AM

Keynote Fireside Chat- Transforming Obesity Healthcare with the Integration of Lifestyle Medicine

  • How can evidence-based lifestyle medicine can be used to effectively address obesity? 
  • How can healthcare providers effectively incorporate lifestyle medicine treatment approaches into obesity treatment?
  • What are the current barriers and challenges in implementing lifestyle medicine approaches in the treatment of obesity, and how can they be overcome?

Kelley Hagerich, Obesity Medicine Physician and National Lead VA MOVE! Weight Management Provider Champions, VA Palo Alto Healthcare Systems & U.S. Department of Veteran Affairs

Michelle Hauser, Clinical Associate Professor, Medicine (Surgery), General Surgery, Primary Care & Population Health, Stanford University School of Medicine

10:05 AM

Presentation- Action on the Social Determinants of Obesity Health Care

  • Analyse the importance of addressing the social determinants of obesity treatment
  • Explore promising practices in addressing the social determinants on obesity health care 
  • Learn about measures needed to address the impact of social determinants of health on treatment outcomes for patients with obesity
10:30 AM

Morning Refreshments and Networking 

11:20 AM

Fireside Chat with Open Q&A- Health Equity: Bridging the Gap

  • How can we ensure equitable access to resources and care for underserved populations who may be disproportionately affected by obesity?
  • What actions are required to overcome obstacles to achieving health equity in obesity treatment? 
  • What role does public policy play in shaping the future of obesity healthcare, and how can policymakers support initiatives that address obesity as a public health priority?

Jamila Freightman, CDC High Obesity  Program Manager, LSU AgCenter

Patrice Harris, Past President, American Medical Association & CEO, eMed Digital Healthcare

Monica Ezue, Director of Health Equity, UnitedHealthcare

11:55 AM

Presentation- Looking Towards the Horizon: Emerging Investment Opportunities

  • Uncover emerging trends in healthcare technologies and investment opportunities in obesity healthcare innovation
  • Discuss the current financial and investment landscape 
  • Explore the emerging investment trends and what new opportunities lie ahead within the obesity healthcare sector

Jon Gordon, Co-Founder & Managing General Partner, HC9 Ventures

12:20 PM

Panel Discussion with Open Q&A: Obesity Innovation: What is the Future of Obesity Healthcare? 

Multidisciplinary approaches will shape the obesity treatments of tomorrow and provide the foundations to curtail the rise in obesity rates. But what innovation needs to happen to help shape this future?

  • What key lessons from the past few years can be implemented to shape the future of obesity healthcare?
  • How will consumer attitudes influence the future landscape of obesity treatment?
  • How will the role of technology and digital health tools help shape the future of obesity healthcare?
  • How can we engage providers, payers, pharma and policy makers to drive meaningful change and innovation?
  • How do you hope obesity health care will change in the next five years?

Nisha Patel, Director, Advanced Organ Therapies Obesity Medicine Program, Sutter West Bay Medical Group

Holly Lofton, Director, Medical Weight Management Program, NYU School of Medicine 

Amanda Powell, Chair, Division of Lifestyle Health, Beth Israel Lahey Health

Moderator: Katherine Saunders, Clinical Assistant Professor of Medicine, Weill Cornell Medicine ; Co-Founder, Intellihealth

1:05 PM

Chair’s Closing Remarks

Download the 2024 Agenda
Co-Located Future of Diabetes Care Summit

Double the Summits, double the content! Conveniently co-located at the Laura Hotel and running simultaneously, Obesity Innovation Summit delegate pass holders will be able to access all session and networking opportunities of the Future of Diabetes Care Summit on a complimentary basis.

View the Agenda for the Future of Diabetes Summit Here.